BioSpace News Archive

Reducing postharvest losses could substantially increase food availability, reducing pressure on the mounting food supply shortage and global inflationary pressures with respect to food prices. In addition, food production could be more environmentally sustainable with less waste.

Rise in the prevalence of different types of cancers such as lung cancer, blood cancer, and brain tumor drives the global digital PCR market.

Rise in awareness regarding early diagnosis of disease, prevalence of infectious diseases, and need for low cost as well as accurate diagnostic testing drive the growth of the global rapid tests market.

Rise in digital dependence and industry 4.0 trends present new opportunities in the coming years. Rise in number of cyber-attacks and increase in demand for cloud services drive the growth of the global healthcare cyber security market.

Viracta Therapeutics, Inc. will host a key opinion leader (KOL) webinar on Nana-val (nanatinostat and valganciclovir) for the treatment of advanced Epstein-Barr virus-positive (EBV+) solid tumors on Wednesday, April 27, 2022, at 11:00 AM EDT.

Increasing incidence of bloodstream infections, sepsis, and infectious diseases is one of the key factors driving market revenue growth.

Increasing adoption of electroceuticals for treatment of various neurological disorders is driving electroceuticals/bioelectric medicine market revenue growth.

Increasing need for real-time health monitoring and increasing need for early detection of diseases are some key factors driving market revenue growth.

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Posaconazole Delayed-Release Tablets, 100 mg, the therapeutic generic equivalent to NOXAFIL® (posaconazole) Delayed-Release Tablets, 100 mg approved by the U.S. Food and Drug Administration (USFDA).

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced today that it plans to release results for the first quarter of 2022 on Wednesday, April 27, at approximately 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.